The Supreme Cannabis Company, Inc. (T:FIRE*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEDAR
Company Contact
Address: 178A Ossington Ave
TORONTO ON M6J 2Z7
Tel: N/A
Website: www.supreme.ca
IR: See website
<
Key People
Michael John La Brier
Independent Chairman of the Board
Dan Sippel
General Manager
Beena Goldenberg
President, Chief Executive Officer, Director
Nikhil Handa
Chief Financial Officer
John Griese
Chief Operating Officer
Joel Toguri
Senior Vice President, Commercial
Dimitre Naoumov
Vice President - Finance
Steve Chan
Vice President - Corporate Affairs & Corporate Secretary
Sunpreet Gokhale
General Counsel and Regulatory Affairs
John Fowler
Chief Advocacy Officer, Managing Director - Flower and Concentrates
   
Business Overview
Supreme Cannabis Company Inc, formerly Supreme Pharmaceuticals Inc, is a Canada-based company. The Company is focused on developing businesses in the cannabis market, with a specific focus on the wholesale sector of the medical cannabis market in Canada. The Company operates an approximately 342,000 square foot greenhouse facility located in Kincardine, Ontario. The Company's subsidiary is 8528934 Canada Ltd., doing business as 7 ACRES, a licensed producer of medical cannabis. 8528934 Canada Ltd. cultivates medical cannabis at its approximately seven acres (over 342,000 square feet) hybrid greenhouse (the Hybrid Greenhouse) facility in Kincardine, Ontario.
Financial Overview
For the nine months ended 31 March 2020, Supreme Cannabis Company Inc revenues increased 32% to C$30.2M. Net loss increased from C$14.1M to C$106.2M. Revenues reflect Gross revenue increase from C$10.3M to C$33.8M. Higher net loss reflects Finance expense, net increase from C$3M to C$12M (expense), Wages and benefits increase of 68% to C$16.4M (expense), Share based payments increase from C$5.8M to C$12.3M (expense).
Employees: 750 as of Jun 30, 2019
Reporting Currency: Canadian Dollars
Enterprise value: $148.37M as of Mar 31, 2020
Annual revenue (TTM): $49.22M as of Mar 31, 2020
EBITDA (TTM): -$72.61M as of Mar 31, 2020
Net annual income (TTM): -$106.59M as of Mar 31, 2020
Free cash flow (TTM): -$109.91M as of Mar 31, 2020
Net Debt Last Fiscal Year: $122.52M as of Mar 31, 2020
Shares outstanding: 354,667,028 as of May 26, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization